Education
About Us
Working with TipRanks
Follow Us
Hsin Tse Insider Profile
4 Followers
Hsin Tse, Senior Vice-President at Sino Biopharmaceutical, holds 358.56M shares in Sino Biopharmaceutical (Ticker: SBMFF). Most recently, Hsin Tse Bought $1,000,000 shares of Sino Biopharmaceutical on Jul 16, 2025 for an estimated value of 6.47M.
Hsin Tse Sino Biopharmaceutical (SBMFF)Senior Vice-President
Sino Biopharmaceutical (SBMFF)
Senior Vice-President
Ranked #90,458 out of 102,830 Corporate Insiders
Profitable Transactions
9 out of 23 Profitable Transactions
Average Return
-14.30%
Average return per transaction
Time Frame
Compare to
Insider Roles
Senior Vice-President
Roles that Hsin Tse holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Jan 06, 2015 - Jan 06, 2016
Return:+50.20%
The most profitable trade made by Hsin Tse
Hsin Tse's Trading History
List of latest transactions for each holding click on a transaction to see Hsin Tse's performance on stock
You May Also Like
Hsin Tse insider profile FAQ
What is the percentage of profitable transactions made by Hsin Tse?
The percentage of profitable transactions made by Hsin Tse is 39%.
What is the average return per transaction made by Hsin Tse?
The average return per transaction made by Hsin Tse is -14.30%.
What stocks does Hsin Tse hold?
Hsin Tse holds: SBMFF stocks.
What was Hsin Tse’s latest transaction?
Hsin Tse latest transaction was an Informative Buy of $6.47M.
What was Hsin Tse's most profitable transaction?
Hsin Tse’s most profitable transaction was an Informative Buy of SBMFF stock on January 6, 2015. The return on the trade was 50.20%.
What is Hsin Tse's role in Sino Biopharmaceutical?
Hsin Tse's role in Sino Biopharmaceutical is Senior Vice-President.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.